Highlights
NASDAQ: LXRX       Lexicon Pharmaceutcl
Last Price Today's Change   Day's Range   Trading Volume
4.86   -0.21 (4.14%)  4.835 - 5.17  922,884

Overview

 
Avg Volume (4 weeks):1,751,547
4 Weeks Range:2.51 - 5.33
4 Weeks Price Volatility (%):
83.33%
52 Weeks Range:1.125 - 8.39
52 Weeks Price Volatility (%):
51.41%
Average Price Target: 1.16
Price Target Upside/Downside: -3.70

Headlines



No recent Headlines for this stock.


Business Background

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. Its drug programs include XERMELO (telotristat ethyl), sotagliflozin, LX2761 and LX9211. It also has a number of additional compounds into various stages of clinical and preclinical development. XERMELO is an orally-delivered small molecule compound approved by the Food and Drug Administration (FDA) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. It is developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for type 1 and type 2 diabetes mellitus. LX2761 is an orally-delivered small molecule compound that it is developing for the treatment of diabetes. LX9211 is an orally-delivered small molecule compound that the Company is developing for the treatment of neuropathic pain.

  Be the first to like this.
 


 

2581  3153  324  2909 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AMD 41.255-1.335 
 CHK 0.782-0.001 
 DHR 148.71-2.59 
 AABA 19.630.00 
 GE 11.355-0.085 
 VIAB 24.22+0.75 
 BAC 34.465-0.215 
 NIO 2.40+0.13 
 F 9.227-0.093 
Partners & Brokers